The Quantellect read.As of Nov 19, 2026, 4 active firms cover Orthofix Medical Inc: 3 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $13.00 to $17.00, so the covering firms are broadly aligned. The average target of $14.75 sits 123% above the current $6.60. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $0.18 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy375%
Neutral125%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$14.75
+123.5% upside
Average target across 4 active firms as of Nov 19, 2026 vs $6.60 current
Highest Target$17.00
Average Target$14.75
Lowest Target$13.00
Detailed analyst forecasts for OFIX
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 3 of 4 active firms rate OFIX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
OFIX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.20 – $-0.20 · 1 analysts · +77% YoY
Next period, 1 analysts expect Orthofix Medical Inc to earn $-0.20 a share (range $-0.20 – $-0.20), versus $-0.11 a year earlier. Full-year consensus is $0.43, growing to $0.18 the year after.
REVENUE · NEXT QUARTER
$190.8M
Range $188.1M – $193.4M · 1 analysts · -3% YoY
Revenue is expected to reach $190.8M (range $188.1M – $193.4M), -3.0% year-over-year. Full-year consensus is $827.1M, rising to $820.0M next year.
Top analysts covering Orthofix Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OFIX.
#1
JW
Jason Wittes
Roth MKM · Rank #382
Buy
$22.00+233.3% to target
Overall win rate
40%
+ Follow
#2
Michael Petusky
Barrington Research · Rank #452
Buy
$17.00+157.6% to target
Overall win rate
32%
+ Follow
#3
David Turkaly
JMP Securities · Rank #453
Neutral
No targeton OFIX
Overall win rate
35%
+ Follow
#4
CB
Caitlin Burrows
Canaccord Genuity
Buy
$13.00+97.0% to target
Coverage
—
+ Follow
#5
TS
Thomas Stephan
Stifel
Buy
$13.00+97.0% to target
Coverage
—
+ Follow
OFIX stock forecast FAQ
What is OFIX's average 12-month price target?+
The 4 active firms with a live target average $14.75 for Orthofix Medical Inc over the next 12 months, ranging from a $17.00 high to a $13.00 low, as of Nov 19, 2026.
Is OFIX stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for OFIX?+
The Street-high target is $17.00 (Barrington Research), and the Street-low is $13.00 (Canaccord Genuity). The average of all 4 active-firm targets is $14.75.
How many active Wall Street firms cover OFIX?+
4 active firms have a recognized rating on Orthofix Medical Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering OFIX?+
Among analysts who currently cover OFIX, Jason Wittes of Roth MKM has the strongest overall Quantellect track record (Rank #382). Their current call is Buy with a $22.00 target.
What is Orthofix Medical Inc's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.20 – $-0.20) across 1 analysts. Full-year EPS is projected at $0.43, rising to $0.18 the following year.
How much revenue is Orthofix Medical Inc expected to report next quarter?+
Consensus revenue is $190.8M (range $188.1M – $193.4M). Full-year revenue is projected at $827.1M, growing to $820.0M next year.
Have analysts been upgrading or downgrading OFIX lately?+
As of Nov 19, 2026, 3 of 4 active firms rate OFIX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OFIX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.